Onconeural antibodies such as anti-Hu and anti-Yo may be important in the pathogenesis of paraneoplastic neurological syndromes. The avidity of these antibodies is not known. In this study, we compared the avidity of Hu and Yo antibodies both at single time points and over a time range of 2 months to 6 years. The avidity of Yo and Hu antibodies differed among the patients, but anti-Yo generally had higher avidity than antiHu. Whether Yo antibodies are more pathogenic than Hu antibodies are presently unknown.
Introduction
Paraneoplastic neurological syndromes (PNS) are characterized by the degeneration of neurons and glia cells caused by cellular and humoral immunity produced as a response to cancer antigens elsewhere in the body. Common onconeural antibodies are anti-Hu and anti-Yo which are associated with various cancers, such as small cell lung cancer, and ovarian or breast cancer, respectively [reviewed in (Roberts and Darnell, 2004) ].
Affinity is defined as the strength of all non-covalent interactions between one single epitope and one single Fab, whereas avidity is defined as the strength of the antibody-antigen interaction when multiple Fabs interact with multiple epitopes (Steward and Lew, 1985) . Affinity towards specific antigens after first exposure is generally low, but long-term exposure results in increased affinity within weeks to months. This happens because somatic mutations are inserted into the variable regions of the immunoglobulin G (IgG) genes, and B cells with this affinity are selected (Fish et al., 1989; Griffiths et al., 1984) .
One of the most frequently used ways of determining avidity is to use a hydrogen bond-disrupting agent such as urea or ammonium thiocyanate to elute low-avidity antibodies from immobilized antigens. Such treatment makes the avidity index (AI) independent of the antibody titer (Joynson et al., 1990) . Antibody avidity measurements have been used to determine the time of onset of several viral diseases, such as respiratory syncytial virus (Meurman et al., 1992) , rubella virus (Hedman and Rousseau, 1989) and parasite infections such as toxoplasmosis (Hedman et al., 1989; Joynson et al., 1990) . As in microbial infections, there is evidence of avidity maturation of antibodies associated with various autoimmune diseases. The avidity of antibodies against β-lactoglobulin and gliadin increases during childhood (Saalman et al., 2003) , and higher acetylcholine receptor avidity has been reported with the duration of myasthenia gravis (Vincent and Newsom-Davis, 1982) . High-avidity islet cell antibodies have been correlated with diabetes (Rulli and Simell, 1999) and high-avidity ds-DNA antibodies with lupus nephritis (Villalta et al., 2003) . On the other hand, the avidity of antibodies against tyrosine phosphatase and glutamic acid decarboxylase did not correlate with diabetes (Westerlund et al., 2005) . As far as we know, this is the first study on the avidity of onconeural antibodies.
Materials and methods

Patients
Avidity was measured on sera from 35 patients with paraneoplastic disease, 21 patients with anti-Hu and 14 patients with anti-Yo, verified by immunohistochemistry and immunoblot with recombinant proteins (Ravo Diagnostica, GmbH, 
